BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 16387076)

  • 21. Important of HLA matching in cadaveric renal transplantation. A prospective one-center study.
    Moen T; Flatmark A; Jervell J; Dahl O; Halvorsen S; Solheim B; Thorsby E
    Scand J Urol Nephrol Suppl; 1981; 64():64-71. PubMed ID: 6815795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation.
    Vu LT; Baxter-Lowe LA; Garcia J; McEnhill M; Summers P; Hirose R; Lee M; Stock PG
    Arch Surg; 2011 Jul; 146(7):824-9. PubMed ID: 21768429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human leukocyte antigens DR and AB and kidney retransplantation.
    Thompson JS; Thacker LR; Krishnan G
    Transplantation; 2003 Mar; 75(5):718-23. PubMed ID: 12640315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of HLA matching for CREG antigens in Europe.
    Wujciak T; Opelz G
    Transplantation; 1999 Oct; 68(8):1097-9. PubMed ID: 10551635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome.
    Caskey FJ; Johnson RJ; Fuggle SV; Start S; Pugh D; Dudley CR
    Transplantation; 2009 Jun; 87(11):1727-32. PubMed ID: 19502967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-DR matching improves survival after heart transplantation: is it time to change allocation policies?
    Kaczmarek I; Deutsch MA; Rohrer ME; Beiras-Fernandez A; Groetzner J; Daebritz S; Schmoeckel M; Spannagl M; Meiser B; Reichart B
    J Heart Lung Transplant; 2006 Sep; 25(9):1057-62. PubMed ID: 16962466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report.
    Opelz G; Döhler B
    Transplantation; 2010 Aug; 90(3):292-7. PubMed ID: 20548266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new epitope-based HLA-DPB matching approach for cadaver kidney retransplants.
    Laux G; Mansmann U; Deufel A; Opelz G; Mytilineos J
    Transplantation; 2003 May; 75(9):1527-32. PubMed ID: 12792509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood transfusions and HLA matching--an either/or situation in cadaveric renal transplantation.
    Cecka JM; Cicciarelli J; Mickey MR; Terasaki PI
    Transplantation; 1988 Jan; 45(1):81-6. PubMed ID: 3276068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of HLA-DR matching in DNA-typed cadaver kidney transplants.
    Opelz G; Mytilineos J; Scherer S; Dunckley H; Trejaut J; Chapman J; Fischer G; Fae I; Middleton D; Savage D
    Transplantation; 1993 Apr; 55(4):782-5. PubMed ID: 7682736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collaborative Transplant Study Kidney Exchange Trial for highly sensitized recipients.
    Opelz G
    Clin Transpl; 1991; ():61-4. PubMed ID: 1820146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The HLA-matching effect in different cohorts of kidney transplant recipients.
    Terasaki PI
    Clin Transpl; 2000; ():497-514. PubMed ID: 11512361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and socioeconomic benefits of serological HLA-DR matching for renal transplantation over three eras of immunosuppression regimens at a single unit.
    Taylor CJ; Welsh KI; Gray CM; Bunce M; Bayne AM; Sutton PM; Gray DW; Ting A; Morris PJ
    Clin Transpl; 1993; ():233-41. PubMed ID: 7918156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HLA compatibility and antigenic re-exposure. Impact on the clinical course of cadaver kidney transplantation].
    Fernández Aparicio T; Miñana López B; Polo Villar G; Diaz González R; Fraile Gómez B; Aguirre Benites F; Morales Cerdán JM; Leiva Galvis O
    Arch Esp Urol; 2000; 53(1):53-64. PubMed ID: 10730425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of HLA compatibility on lung transplant survival and evidence for an HLA restriction phenomenon: a collaborative transplant study report.
    Opelz G; Süsal C; Ruhenstroth A; Döhler B
    Transplantation; 2010 Oct; 90(8):912-7. PubMed ID: 20808265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA matching effect on five-year graft survival and half-life in the cyclosporine era.
    Mitsuishi Y; Terasaki PI
    Kidney Int Suppl; 1992 Oct; 38():S172-5. PubMed ID: 1405371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a differential strength of specific HLA mismatches in kidney transplants?
    Sasaki N; Idica A; Terasaki P
    Transplant Proc; 2008 May; 40(4):1091-4. PubMed ID: 18555121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA matching effects.
    Mickey MR
    Clin Transpl; 1987; ():303-16. PubMed ID: 3154423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Taboo HLA mismatches in cadaveric renal transplantation: definition, analysis, and possible implications.
    Doxiadis II; Smits JM; Stobbe I; Schreuder GM; Persijn GG; van Houwelingen H; van Rood JJ; Claas FH
    Transplant Proc; 1996 Feb; 28(1):224. PubMed ID: 8644189
    [No Abstract]   [Full Text] [Related]  

  • 40. The economic implications of HLA matching in cadaveric renal transplantation.
    Schnitzler MA; Hollenbeak CS; Cohen DS; Woodward RS; Lowell JA; Singer GG; Tesi RJ; Howard TK; Mohanakumar T; Brennan DC
    N Engl J Med; 1999 Nov; 341(19):1440-6. PubMed ID: 10547408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.